A new blood test has an 80% accuracy in predicting preterm preeclampsia, according to a study published today, Feb. 12, in ...

Purpose: Pharmacotherapeutic options for the treatment of preeclampsia are reviewed. Summary: Risk factors for the development of preeclampsia include microvascular diseases, such as diabetes ...

Magnesium sulfate remains the drug of choice for the prevention and treatment of preeclampsia. Alternative antihypertensive agents may provide additional benefit in the management of hypertension ...

Preeclampsia in pregnancy is a condition characterized by high blood pressure and high protein in the urine during pregnancy or right after delivery. It usually develops after 20 weeks of pregnancy.

Previous trials have used a wide range of doses, from 60-150 mg daily. In terms of prophylaxis for people at high risk of ...

The Preeclampsia Foundation launched a new initiative that aims to close the maternal health equity gap and promote the use ...

It's long been known that certain complications of pregnancy can raise a woman's risk for heart trouble years later.But ...

Recent preeclampsia studies have investigated predictors such as placenta location and PAPP-A, in addition to comparing the P/C ratio with 24-hour proteinuria.

The Preeclampsia Foundation announced today the recipients of its 2025 Peter Joseph Pappas Research Grants. Based on the recommendations of its Scientific Advisory Council, the Preeclampsia Foundation ...

In recognition of January 23rd as Maternal Health Awareness Day, the Preeclampsia Foundation in partnership with Patients & Purpose announc ...